this post was submitted on 28 Aug 2023
1 points (100.0% liked)

Public Health

375 readers
3 users here now

For issues concerning:

🩺 This community has a broader scope so please feel free to discuss. When it may not be clear, leave a comment talking about why something is important.

Related Communities

See the pinned post in the Medical Community Hub for links and descriptions. link (!medicine@lemmy.world)

Rules

Given the inherent intersection that these topics have with politics, we encourage thoughtful discussions while also adhering to the mander.xyz instance guidelines.

Try to focus on the scientific aspects and refrain from making overly partisan or inflammatory content

Our aim is to foster a respectful environment where we can delve into the scientific foundations of these topics. Thank you!

founded 1 year ago
MODERATORS
otter@mander.xyz
otter@lemmy.ca
1
A drug development model for the diseases the world forgot (africanarguments.org)
submitted 1 year ago by mwalimu@baraza.africa to c/publichealth@mander.xyz
0 comments fedilink hide all child comments
 

cross-posted from: https://baraza.africa/post/451001

Neglected tropical diseases, such as visceral leishmaniasis, primarily affect people in the world’s poorest regions. Unfortunately, commercially driven medical research tends to overlook these populations because they are believed to lack the financial means to constitute a lucrative market for the traditional pharmaceutical industry. Drug development today is primarily skewed to areas with the greatest commercial return rather than those with the greatest public health needs.

But the alternative model that my organization, the Drugs for Neglected Diseases Initiative (DNDi), and our partners have pioneered since 2003 focuses on areas of the greatest need rather than the greatest profit. This means that we prioritize the development of treatments for diseases that have a high impact on public health, even if they are not directly profitable for the companies that develop them.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here